Inspection Findings:
3. Resident 2 was admitted to the facility in 04/2022 with diagnoses including chronic pain and rheumatoid arthritis. The resident's 02/08/23 through 05/08/23 progress notes, 04/04/23 physician orders, 04/04/23 through 05/10/23 physician communications, and the 04/01/23 through 05/08/23 MAR/TAR were reviewed.During the acuity interview on 05/08/23, the resident was identified to self-administer only his/her insulin. In subsequent interviews with Staff 15 (MT) and Staff 25 (MT), they indicated the resident self-administered his/her own insulin and facility staff did the rest.In interviews on 05/08/23 and 05/09/23, Resident 2 indicated s/he self-administered only his/her Nystatin cream and both insulins. The resident showed the surveyor where s/he kept these items and the extra supplies. The resident denied s/he had any additional medications or treatments in his/her room.The 04/04/23 physician orders and 04/01/23 through 05/08/23 MARs/TARs showed the following:* An order for Omeprazole 40 mg, give two tablets by mouth every morning before breakfast for heartburn. The MARs reflected staff were to administer Omeprazole 40 mg, give one tablet every morning.* Glucose Gel 40%, administer PRN for blood sugars less than 70 and resident awake. The MARs did not reflect the order for staff to administer this medication.* Hydroxyzine HCL 25 mg, give one tablet by mouth three times a day PRN for anxiety or itching. The order indicated the resident self-administered the medication. The MARs did not reflect an order for staff to administer this medication. * Rizatriptan Benzoate 10 mg tablet, give one tablet by mouth PRN for migraines. The order indicated the resident could self-administer and keep at bedside. The MARs did not reflect an order for staff to administer this medication.* Loperamide, give two capsules by mouth once a day PRN for first loose stool and one capsule PRN for additional loose stools. The MARs did not reflect an order for staff to administer this medication.* Calazime Skin Protectant Paste, apply Calazime three times daily PRN to sacral area. The order indicated the resident could self-administer and keep at bedside. The MARs did not reflect an order for staff to administer this treatment.The need to ensure the facility administered all medications and treatments as ordered by the physician was discussed with Staff 1 (ED), Staff 2 (LPN), Staff 4 (RN) and Staff 16 (Operations Specialist) on 05/11/23. The staff acknowledged the findings.4. Resident 4 was admitted to the facility in 03/2023 with diagnoses including chronic pain. The resident's 03/18/23 through 05/08/23 progress notes, 03/16/23 physician orders, 03/16/23 through 05/10/23 physician communications, and the 04/01/23 through 05/08/23 MAR/TAR were reviewed.The 04/04/23 physician orders and 04/01/23 through 05/08/23 MARs/TARs showed the following:* Lyrica 100 mg caplets, give twice a day for chronic pain.* The MARs showed the resident received the Lyrica 100 mg caplets, three times a day from 03/18/23 to 04/05/23.* The resident only one dose of the Lyrica on 04/07/23, 04/08/23 and 04/11/23.* The resident received zero doses of the prescribed Lyrica on 04/09/23 and 04/10/23.A fax to the physician was sent on 04/07/23 which indicated the resident was out of his/her Lyrica due to the wrong dosage being given at the facility. Staff requested a refill as soon as possible for the resident. The medication was noted as twice a day beginning on 04/12/23. The need to ensure the facility administered all medications and treatments as ordered by the physician was discussed with Staff 1 (ED), Staff 2 (LPN), Staff 4 (RN) and Staff 16 (Operations Specialist) on 05/11/23. The staff acknowledged the findings.
Based on interview and record review, it was determined the facility failed to ensure orders were carried out as prescribed for all medications and treatments the facility was responsible to administer, for 5 of 5 sampled residents (#s 1, 2, 3, 4 and 5) whose orders were reviewed. Findings include, but are not limited to:1. Resident 3 was admitted in 02/2021 with diagnoses including chronic obstructive pulmonary disease and high cholesterol. Resident 3's MARs from 04/01/23 through 05/08/23 and physician orders were reviewed and showed the following:* An order for acetaminophen (for pain) 325 mg, two tablets at 8 am, 2 pm and 8 pm. There was no documented evidence on the MAR the medication was administered on 04/12/23, 04/13/23 and 04/18/23 at 2pm;* Atorvastatin (for high cholesterol) 20 mg, one tablet at bedtime. The order transcribed onto the MARs instructed staff to administer the medication at 8 am; * Divalproex (for panic disorder) 250 mg, one tablet at 8 am, 12 pm and 8 pm. There was no documented evidence on the MAR the medication was administered on 04/02/23 and 04/12/23 at 12 pm; and* Gabapentin (for back pain) 300 mg, one capsule at 8 am, 12 pm and 8 pm. There was no documented evidence on the MAR the medication was administered on 04/02/23 and 04/12/23 at 12 pm. The need to ensure physician orders were carried out as prescribed was reviewed with Staff 1 (ED), Staff 4 (RN) and Staff 26 (Director of Operations) on 05/11/23. They acknowledged the findings. 2. Resident 5 was admitted to the facility in 09/2021 with diagnoses including major depressive disorder. Resident 5's MARs from 04/01/23 through 05/08/23 and physician orders were reviewed and showed the following:*An order for acetaminophen (for pain) 500 mg one tablet every six hours as needed for pain. The order transcribed onto the MARs instructed staff to administer two tablets every six hours as needed for pain. During an interview on 05/11/23, Staff 4 (RN) confirmed the medication order was transcribed incorrectly.The need to ensure physician orders were carried out as prescribed was reviewed with Staff 1 (ED), Staff 4 and Staff 26 (Director of Operations) on 05/11/23. They acknowledged the findings.
5. Resident 1 was admitted to the facility in 08/2022 with diagnoses including hypertension. Resident 1's 04/01/23 through 05/08/23 MARs and signed physician orders dated 03/08/23 were reviewed and identified the following:* The physician's order for hydralazine (for high blood pressure) three times per day included parameters to hold the medication if the resident's systolic blood pressure was less than 120. On 04/07/23, 04/12/23, 04/13/23, 04/14/23, and 04/18/23, the resident had a systolic blood pressure reading below 120, and staff administered the medication when it should have been held; and* The physician's order for losartan (for high blood pressure) one time per day included parameters to hold the medication if the resident's systolic blood pressure was less than 120. On 04/02/23, 04/23/23, and 05/12/23, the resident had a systolic blood pressure reading below 120 and staff administered the medication when it should have been held.The need to ensure the facility administered all medications and treatments as ordered by the physician was discussed with Staff 1 (ED), Staff 2 (LPN), Staff 4 (RN) and Staff 26 (Director of Operations) on 05/11/23. The staff acknowledged the findings.
Based on interview and record review, it was determined the facility failed to ensure written, signed physician orders were documented in residents' records for all medications and treatments provided by the facility, that residents' MARs reflected these orders, and the orders were carried out as prescribed for 4 of 5 sampled residents (#s 2, 7, 9 and 10) whose orders were reviewed. This is a repeat citation. Findings include, but are not limited to:1. Resident 7 was admitted to the facility 02/2021 with diagnoses including epilepsy, hypertension, and congestive heart failure. Review of Resident 7's MAR, dated 10/01/23 through 11/06/23, and current physician orders identified the following deficiencies:There were no written, signed orders for the following medications on the resident's MAR:* Acetaminophen 325 mg PRN (for pain or fever);* Hydrocodone 5 mg/ acetaminophen 325 mg PRN (for pain);* Lyrica 50 mg (for symptomatic epilepsy); and* ZEASORB AF (anti-fungal)There was no documentation on the resident's MAR for the following ordered medications:* Apixaban 5 mg (anticoagulant);* Cyclobenzaprine 10 mg PRN (for muscle spasm);* Dextromethorphan 10 mL PRN (for cough);* Diclofenac gel 1% PRN (for moderate pain);* Docusate sodium 100 mg (bowel health);* Geri-kot tab 8.6 mg (bowel health);* Lactulose 10 gm/15mL PRN (for constipation); and* Polyethylene glycol 3350 PRN (for constipation)In an interview on 11/08/23, Staff 5 (Med Room Manager) confirmed the orders provided were the most current signed set, and there were no other subsequent individual medication orders.On 11/09/23, the need to ensure written, signed orders were documented for all medications and treatments provided by the facility, that residents' MARs reflected these orders was discussed with Staff 2 (LPN) and Staff 29 (Interim ED). They acknowledged the findings.
3. Resident 9 was admitted to the facility in 02/2021 with diagnoses including epilepsy and traumatic brain injury.Resident 9's 10/01/23 through 11/06/23 MARs and physician orders were reviewed. The following was identified:*An order for acetaminophen (for pain) 325 mg two tablets every four hours as needed for pain. The order transcribed onto the MARs labeled acetaminophen as "650 mg" tablets and instructed staff to administer two tablets (650mg) every four hours as needed for pain 1-4/10; *An order for selenium sulfide (for dry scalp) apply up to three times per week during showers as needed for dandruff and dry scalp. The order transcribed onto the MARs instructed staff to apply up to three times per week and one time during showers as needed; and *Divalproex sodium (for epilepsy) 500 mg, two tablets at 8:00 am and 8:00 pm. There was no evidence that the medication was given on 10/14/23 at 8:00 pm. The need to ensure physician orders were carried out as prescribed was reviewed with Staff 29 (Interim ED) and Staff 2 (LPN) on 11/09/23. They acknowledged the findings.4. Resident 10 was admitted to the facility on 02/2021 with diagnoses including hypertension.Resident 10's 11/01/23 through 11/08/23 MAR was reviewed and showed the following:* An order for metoprolol tartrate (for abnormal heart rhythm) 25 mg two tablets at 8:00 am and one tablet at 8:00 pm. Records indicated Resident 10 missed his/her 8:00 pm dose on 11/06/23 and the 8:00 am doses on 11/07/23 and 11/08/23 because "medication unavailable." The resident did receive his/her 8:00 pm dose on 11/07/23. The MAR indicated the medication was unavailable.In an interview on 11/08/23 at 2:40 pm with Staff 38 (MT), she stated that Resident 10 received his/her 8:00 pm dose on 11/07/23 but not on 11/06/23 because the medication cart was "so full" on 11/06/23 from a cycle fill delivery that the medication could not be located. After the cart was organized the medication was found and Resident 10 received the medication for the 8:00 pm dose on 11/07/23. The need to ensure physician orders were carried out as prescribed was reviewed with Staff 29 (Interim ED) and Staff 2 on 11/09/23. They acknowledged the findings.
2. Resident 2 was admitted to the facility in 06/2014 with diagnoses including depression, anxiety, and diabetes.A review of the resident's clinical record, including progress notes dated 08/10/23 through 11/06/23, 10/01/23 through 11/06/23 MARs, and current physician orders was completed, and staff were interviewed. The following deficiencies were identified:a. Resident 2 had an order for cephalexin (an antibiotic) 500 mg, two capsules two times a day for 10 days. The 10/2023 MAR indicated the following:* The medication was entered on the MAR for one capsule two times daily, and the resident was administered only one capsule on 10/19/23 and once on 10/20/23. At that time the order was entered on the MAR again and the resident received the evening dose of the medication on 10/20/23; and* The MAR indicated the resident did not receive the medication at all on 10/28/23 and 10/29/23 and only one administration on 10/30/23.In an interview on 11/07/23, Staff 5 (Med Room Manager) reported the "home office" had audited the MAR and made a change staff were not aware of. A progress note on 11/01/23 written by Staff 5 indicates when the home office made the change "the days were not transferred over." She stated the resident did receive the remainder of the antibiotic.b. The resident had a physician order for cyclobenzaprine (a muscle relaxer) 5 mg once a day as needed for muscle spasms. The MAR indicated the resident received the PRN twice on 10/04/23 and 10/06/23 and three times on 10/17/23.In an interview on 11/07/23, Staff 2 (LPN) acknowledged the PRN had been administered more frequently than the physician had prescribed. c. The resident had an order for diclofenac sodium external gel 1% (a topical pain reliever) to be administered four times per day. The MAR indicated the resident did not receive the treatment on one of four administration times on 10/06/23 and on three of four administration times on 10/07/23.In an interview on 11/07/23, Staff 2 acknowledged the finding.d. The MAR indicated the resident should be treated with Nystatin External Ointment every other day "on rotation" with clobetasol 0.5% (both medications for itching). There was no physician order for the Nystatin to be administered every other day.A current order reflecting the documentation on the MAR for the Nystatin was requested on 11/07/23, and a physician order for Nystatin to be applied once daily was provided 11/07/23. An order to apply Nystatin every other day "on rotation" with clobetasol was requested again on 11/08/23. No further documentation was provided.The need to follow physician orders as written and to have orders for all medications the facility was responsible for administering to the resident was discuss with Staff 29 (Interim Director), Staff 2 (LPN), Staff 16 (Operation Specialist (Corporate)), and Staff 37 (Operational Specialist) on 11/09/23. No additional information was provided.